Sign Up to like & get recommendations! 2
Published in 2021 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2021.1232
Abstract: Importance There are limited clinical trial data and discrepant recommendations regarding use of anticoagulation therapy in patients with atrial fibrillation (AF) aged 65 to 74 years without other stroke risk factors. Objectives To evaluate the… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2022.3591
Abstract: Importance The optimal treatment of intermediate-high-risk pulmonary embolism (PE) remains unknown. Objective To assess the effect of conventional catheter-directed thrombolysis (cCDT) plus anticoagulation vs anticoagulation monotherapy in improving echocardiographic measures of right ventricle (RV) to… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.9973
Abstract: Key Points Question What trends in patient characteristics, anticoagulation treatment, and prognosis were associated with patients with incident nonvalvular atrial fibrillation (NVAF) in the Netherlands in 2014 to 2018? Findings In this cohort study that… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Annals of neurology"
DOI: 10.1002/ana.26654
Abstract: BACKGROUND Atrial fibrillation (AF) known before ischemic stroke (KAF) has been postulated to be an independent category with a recurrence risk higher than that of AF detected after stroke (AFDAS). However, it is unknown whether… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "AORN Journal"
DOI: 10.1002/aorn.12115
Abstract: M anticoagulation therapy for patients undergoing surgery can present many challenges for the perioperative team. Each patient has a unique set of comorbidities that affects their risks for bleeding and clotting and must be assessed… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28370
Abstract: Anticoagulation is of paramount importance during left atrial appendage occlusion procedure (LAAOP) to prevent periprocedural stroke. We present the case of a 66‐year‐old male patient who was scheduled to undergo LAAOP because of a prior… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Clinical Cardiology"
DOI: 10.1002/clc.22755
Abstract: To the Editor: Dabigatran is a novel oral anticoagulant agent that can be used in fixed-dose regimens for anticoagulation in patients with atrial fibrillation, deep venous thrombosis (DVT), or pulmonary embolism (PE). However, the scientific… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2504
Abstract: Coronavirus disease 2019 (COVID‐19) is associated with a hypercoagulable state. It has been hypothesized that higher‐dose anticoagulation, including therapeutic‐dose and intermediate‐dose anticoagulation, is superior to prophylactic‐dose anticoagulation in the treatment of COVID‐19. This meta‐analysis evaluated… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21592
Abstract: We surveyed multiple apheresis centers represented by the authors for their clinical approach to the management of anticoagulation issues during therapeutic plasma exchange (TPE). We present the results of their practices and a review of… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.22019
Abstract: Double‐filtration plasmapheresis (DFPP) has been utilized for immunomodulation in kidney transplantation. Anticoagulation is important to maintain circuit patency during DFPP. We aimed to compare the efficacy and safety of regional citrate anticoagulation (RCA) with systemic… read more here.